Harmony Biosciences Holdings

Healthcare · Biotechnology

41.30$ +0.2% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Harmony Biosciences Holdings (HRMY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,373 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet HRMY
Line item	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	778	811	847	858	928	999	1,056	1,108	1,208	1,272	1,272	1,373
Current Assets	463	451	480	458	522	579	643	691	839	907	779	814
Cash	325	312	333	317	387	453	489	546	647	753	589	550
Cash & Short-Term Investments	371	353	372	347	410	467	507	565	673	775	641	668
Receivables	67	74	80	83	82	83	106	93	101	97	108	111
Inventory	5.1	5.4	5.9	5.6	6.9	7.2	6.4	6.1	6.9	5.4	5.3	6.4
Intangible Assets	143	137	131	125	119	113	107	101	95	89	83	77
Total Liabilities	296	344	332	320	331	340	335	335	373	401	361	374
Current Liabilities	112	164	154	147	161	175	175	180	223	252	217	234
Short-Term Debt	17	16	17	17	17	18	19	20	21	87	63	20
Accounts Payable	6.5	18	15	23	11	14	17	28	26	18	29	22
Long-Term Debt	182	179	175	171	168	163	158	153	149	144	139	134
Shareholders' Equity	481	467	515	539	597	659	721	773	835	870	910	999
Retained Earnings	-170	-143	-105	-93	-47	2.2	48	88	138	161	193	269
Shares Outstanding	61	59	58	58	58	58	59	58	59	59	59	59

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings